NCT06190821RecruitingNot Applicable
Hydrodissection of the Hepatoduodenal Ligament
University Hospital, Strasbourg, France1 site in 1 country13 target enrollmentStarted: July 20, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 13
- Locations
- 1
- Primary Endpoint
- Retrospective description of the hepatoduodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum
Study Overview
Brief Summary
Percutaneous treatment of liver lesions adjacent to the duodenum exposes the duodenum to the risk of thermal injury, limiting removal and oncologic outcome. In this study the investigators investigate the feasibility of hepato duodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Opposition to the reuse of his/her data for the purpose of scientific research.
Outcomes
Primary Outcomes
Retrospective description of the hepatoduodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum
Time Frame: Files analysed retrospectively from January 01, 2019 to July 31, 2022 will be examined
This study is retrospective
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Hepato-duodenal Ligament Occlusion and Classic Technique in Liver TransplantLiver TransplantNCT04265157Assiut University50
Completed
Not Applicable
Side-to-side Duodenojejunostomy After Distal Duodenal Resection (DUORESECT)Duodenal NeoplasmGastrointestinal DiseaseSurgery--ComplicationsSurvivalNCT04151394Universidad de Extremadura13
Recruiting
Not Applicable
Transjugular liver biopsy for liver damage after hematopoietic stem cell trasnplantatioliver damage after hematopoietic stem cell transplantationJPRN-UMIN000017752nivesity of Tokyo Hospital, Department of Hematology and Oncology30
Unknown
Phase 1
Prevention of Liver Damage During Liver SurgeryLiver TumorsNCT00845689Ludwig-Maximilians - University of Munich
Completed
Not Applicable
Ischemic Preconditioning at a Distance in Liver SurgeryLiver DiseasesNCT04181502University Hospital, Lille46